Zogenix, Inc. (ZGNX): Price and Financial Metrics


Zogenix, Inc. (ZGNX)

Today's Latest Price: $25.08 USD

1.39 (5.87%)

Updated Feb 28 12:00am

Add ZGNX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ZGNX Stock Summary

  • Of note is the ratio of Zogenix Inc's sales and general administrative expense to its total operating expenses; only 5.72% of US stocks have a lower such ratio.
  • With a price/sales ratio of 1,421.15, Zogenix Inc has a higher such ratio than 99.72% of stocks in our set.
  • In terms of twelve month growth in earnings before interest and taxes, Zogenix Inc is reporting a growth rate of 175.17%; that's higher than 93.07% of US stocks.
  • Stocks that are quantitatively similar to ZGNX, based on their financial statements, market capitalization, and price volatility, are CRMD, WKHS, BPMX, NLNK, and SAGE.
  • Visit ZGNX's SEC page to see the company's official filings. To visit the company's web site, go to www.zogenix.com.
ZGNX Daily Price Range
ZGNX 52-Week Price Range

ZGNX Stock Price Chart More Charts


ZGNX Price/Volume Stats

Current price $25.08 52-week high $57.22
Prev. close $23.69 52-week low $18.27
Day low $22.46 Volume 1,638,000
Day high $25.16 Avg. volume 1,205,792
50-day MA $45.62 Dividend yield N/A
200-day MA $44.51 Market Cap 1.11B

Zogenix, Inc. (ZGNX) Company Bio


Zogenix develops and commercializes therapies for the treatment of central nervous system disorders. The company was founded in 2006 and is based in San Diego, California.


ZGNX Latest News Stream


Event/Time News Detail
Loading, please wait...

ZGNX Latest Social Stream


Loading social stream, please wait...

View Full ZGNX Social Stream

ZGNX Price Returns

1-mo -49.97%
3-mo -47.51%
6-mo -41.25%
1-year -53.51%
3-year 142.32%
5-year 85.50%
YTD -51.89%
2019 42.98%
2018 -8.96%
2017 229.63%
2016 -17.57%
2015 34.49%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6013 seconds.